Clinical Surveillance Vs. Anticoagulation for Low-risk Patients with Isolated Subsegmental Pulmonary Embolism
Phase 4
Recruiting
- Conditions
- Pulmonary EmbolismEmbolismEmbolism and ThrombosisLung DiseasesRespiratory Tract DiseasesVenous ThromboembolismBleedingCardiovascular DiseasesAnticoagulant-induced Bleeding
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-02-10
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Drahomir Aujesky
- Target Recruit Count
- 276
- Registration Number
- NCT04263038
- Locations
- 🇧🇪
Centre hospitalier universitaire de Liege, Liège, Belgium
🇧🇪Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe, Belgium
🇨🇦The Ottawa Hospital, Ottawa, Canada
© Copyright 2025. All Rights Reserved by MedPath